These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11776365)

  • 1. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease.
    Gallena S; Smith PJ; Zeffiro T; Ludlow CL
    J Speech Lang Hear Res; 2001 Dec; 44(6):1284-99. PubMed ID: 11776365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Levodopa + Carbidopa on the Laryngeal Electromyographic Pattern in Parkinson Disease.
    Noffs G; de Campos Duprat A; Zarzur AP; Cury RG; Cataldo BO; Fonoff E
    J Voice; 2017 May; 31(3):383.e19-383.e23. PubMed ID: 27839704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voice Quality and Orofacial Strength as Outcome of Levodopa Effectiveness in Patients with Early Idiopathic Parkinson Disease: A Preliminary Report.
    Lechien JR; Blecic S; Ghosez Y; Huet K; Harmegnies B; Saussez S
    J Voice; 2019 Sep; 33(5):716-720. PubMed ID: 29724466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundamental frequency change during offset and onset of voicing in individuals with Parkinson disease.
    Goberman AM; Blomgren M
    J Voice; 2008 Mar; 22(2):178-91. PubMed ID: 16950600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orofacial Strength and Voice Quality as Outcome of Levodopa Challenge Test in Parkinson Disease.
    Lechien JR; Delsaut B; Abderrakib A; Huet K; Delvaux V; Piccaluga M; Khalife M; Harmegnies B; Saussez S; Blecic S
    Laryngoscope; 2020 Dec; 130(12):E896-E903. PubMed ID: 32239775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems.
    Plowman-Prine EK; Okun MS; Sapienza CM; Shrivastav R; Fernandez HH; Foote KD; Ellis C; Rodriguez AD; Burkhead LM; Rosenbek JC
    NeuroRehabilitation; 2009; 24(2):131-44. PubMed ID: 19339752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of levodopa on vocal function in Parkinson's disease.
    Sanabria J; Ruiz PG; Gutierrez R; Marquez F; Escobar P; Gentil M; Cenjor C
    Clin Neuropharmacol; 2001; 24(2):99-102. PubMed ID: 11307045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involuntary expiratory phonation as a dose-related consequence of L-dopa therapy in a patient with Parkinson's disease.
    Ishii K; Kumada M; Ueki A; Yamamoto M; Hirose H
    Ann Otol Rhinol Laryngol; 2003 Dec; 112(12):1040-2. PubMed ID: 14703107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
    Pinho P; Monteiro L; Soares MFP; Tourinho L; Melo A; Nóbrega AC
    Codas; 2018 Oct; 30(5):e20170200. PubMed ID: 30304100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states.
    Goberman A; Coelho C; Robb M
    J Commun Disord; 2002; 35(3):217-39. PubMed ID: 12064785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Supraglottic Activity and Spectral Slope Between Theater Actors and Vocally Untrained Subjects.
    Guzman M; Ortega A; Olavarria C; Muñoz D; Cortés P; Azocar MJ; Cayuleo D; Quintana F; Silva C
    J Voice; 2016 Nov; 30(6):767.e1-767.e8. PubMed ID: 26725552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional electrical stimulation of laryngeal adductor muscle restores mobility of vocal fold and improves voice sounds in cats with unilateral laryngeal paralysis.
    Katada A; Nonaka S; Adachi M; Kunibe I; Arakawa T; Imada M; Hayashi T; Zealear DL; Harabuchi Y
    Neurosci Res; 2004 Oct; 50(2):153-9. PubMed ID: 15380322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
    Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging.
    Baker KK; Ramig LO; Luschei ES; Smith ME
    Neurology; 1998 Dec; 51(6):1592-8. PubMed ID: 9855507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voice quality severity and responsiveness to levodopa in Parkinson's disease.
    Cushnie-Sparrow D; Adams S; Abeyesekera A; Pieterman M; Gilmore G; Jog M
    J Commun Disord; 2018; 76():1-10. PubMed ID: 30053648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F
    Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For better or worse: The effect of levodopa on speech in Parkinson's disease.
    Ho AK; Bradshaw JL; Iansek R
    Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraglottic activity: evidence of vocal hyperfunction or laryngeal articulation?
    Stager SV; Bielamowicz SA; Regnell JR; Gupta A; Barkmeier JM
    J Speech Lang Hear Res; 2000 Feb; 43(1):229-38. PubMed ID: 10668665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Instructions to Manipulate Specific Parameters of Laryngeal Function Associated with Auditory-Perceptual Ratings of Voice Quality in Nondisordered Speakers?
    Madill CJ; Sheard C; Heard R
    J Voice; 2017 Jul; 31(4):504.e21-504.e33. PubMed ID: 27993501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.